Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
122,308,038
Share change
-8,017,072
Total reported value
$2,770,590,650
Put/Call ratio
19%
Price per share
$22.63
Number of holders
272
Value change
-$153,668,109
Number of buys
151
Number of sells
120

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q3 2025

As of 30 Sep 2025, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 272 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,308,038 shares. The largest 10 holders included Avoro Capital Advisors LLC, VANGUARD GROUP INC, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, BlackRock, Inc., AQR CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, STATE STREET CORP, and EcoR1 Capital, LLC. This page lists 272 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.